Mobius® iFlex Bioreactor
Biopharmaceutical molecule pipelines are diversifying, with an increasing number of candidates and new modalities. To keep up with this evolution, cell culture processes are evolving to deliver higher productivity while increasing the speed to market with reduced risk. To achieve higher outputs, process engineers must be ready to work on upstream process intensification and perfusion without forgetting traditional fed-batch, from seed train to the production bioreactor.
Efficiently implementing process intensification requires a combination of several different technologies, namely bioreactors capable of supporting high cell densities. The Mobius® iFlex Bioreactor is a scalable family of single-use bioreactors, suitable for process development and commercial manufacturing. With optional and configurable modules designed to adapt to a variety of control strategies, biopharmaceutical manufacturers can switch from fed-batch to perfusion and be highly responsive to market demand, uncertainty, or a change in strategy. Learn more about this next generation single-use modular bioreactor for fed-batch and perfusion processes.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.